Eric Weinberg
CIK: 0001295814
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RxSight, Inc.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Sep 15, 2026RXST
RxSight, Inc.
Exercise(M)Direct35.2K shares at avg. $4.34$153K - Sep 5, 2026RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
32.3K shares- - Sep 5, 2026RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
82.6K shares- - Sep 5, 2026RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
59.5K shares- - Sep 5, 2026RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
94K shares- - Sep 5, 2026RXST
RxSight, Inc.
Disposition(D)DirectStock option (right to buy)
87.4K shares- - Sep 5, 2026RXST
RxSight, Inc.
Disposition(D)DirectStock Option (right to buy)
95K shares- - Sep 5, 2026RXST
RxSight, Inc.
Disposition(D)DirectStock Option (right to buy)
92.2K shares- - Sep 5, 2026RXST
RxSight, Inc.
Disposition(D)DirectStock Option (right to buy)
50K shares- - Sep 5, 2026RXST
RxSight, Inc.
Disposition(D)DirectStock Option (right to buy)
125K shares- - Sep 5, 2026RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
65.7K shares- - Sep 2, 2026RXST
RxSight, Inc.
Sale(S)Direct2K shares at avg. $6.96$14K - Aug 31, 2026RXST
RxSight, Inc.
Exercise(M)Direct5.4K shares- - Feb 27, 2026RXST
RxSight, Inc.
Award(A)DirectRestricted Stock Unit
32.2K shares- - Jun 2, 2025RXST
RxSight, Inc.
Exercise(M)Direct188K shares at avg. $3.93$739K - Feb 27, 2025RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
125K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 | RXST RxSight, Inc. | Exercise(M) | 35,168 | $4.34 | $152,629 | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 32,258 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 82,608 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 59,483 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 93,984 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Disposition(D) Stock option (right to buy) | 87,437 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Disposition(D) Stock Option (right to buy) | 95,000 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Disposition(D) Stock Option (right to buy) | 92,200 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Disposition(D) Stock Option (right to buy) | 50,000 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Disposition(D) Stock Option (right to buy) | 125,000 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 65,742 | - | - | Direct |
| Sep 2, 2026 | RXST RxSight, Inc. | Sale(S) | 2,041 | $6.96 | $14,205 | Direct |
| Aug 31, 2026 | RXST RxSight, Inc. | Exercise(M) | 5,370 | - | $0 | Direct |
| Feb 27, 2026 | RXST RxSight, Inc. | Award(A) Restricted Stock Unit | 32,218 | - | - | Direct |
| Jun 2, 2025 | RXST RxSight, Inc. | Exercise(M) | 188,002 | $3.93 | $738,848 | Direct |
| Feb 27, 2025 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 125,000 | - | - | Direct |
1-16 of 16 transactions
About Weinberg Eric
Weinberg Eric (SEC CIK 0001295814) files insider reports with the SEC as Officer of RxSight, Inc. (RXST).
Signal8 holds 6 ownership filings by Weinberg Eric, all Form 4s, filed between Feb 27, 2025 and Sep 16, 2026. Those filings report 16 transactions, from Feb 27, 2025 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Weinberg Eric's filings is in ALISO VIEJO, CA.
Recent filings by Weinberg Eric
- Sep 15, 2026: Option exercise of RXST shares (Form 4, code M).
- Sep 5, 2026: Grants or awards of RXST derivative securities (4 lines, Form 4, code A).
- Sep 5, 2026: Disposition to issuer transactions of RXST derivative securities (5 lines, Form 4, code D).
- Sep 5, 2026: Grant or award of RXST derivative securities (Form 4, code A).
- Sep 2, 2026: Open-market sale of RXST shares (Form 4, code S).
Other insiders filing for RxSight, Inc. (RXST)
- Wilterding Mark, Chief Financial Officer
- Kurtz Ronald M MD, Chief Medical Officer
- Goldshleger Ilya, Chief Operating Officer
- Mottiwala Aziz, President and CEO
- Warner Robert Keith, Director
- PALMISANO ROBERT J, Director